Submit an Article to Pharmacy HQ     
Please include the author's name, title, and citations.     

ANTHIM- obiltoxaximab solution

  1. Patient Information
  2. Inform Patients That:
  3. Manufactured By:

Patient Information 

Advise the patient to read the FDA-approved patient labeling (Patient Information)

Efficacy Based on Animal Models Alone

Inform Patients That: 

  • The effectiveness of ANTHIM has been studied only in animals with inhalational anthrax. ANTHIM has not been tested in people who have inhalational anthrax.
  • The safety of ANTHIM has been studied in healthy adults, but no safety data are available in pediatric patients or pregnant women. Limited data are available in geriatric subjects[see Use in Specific Populations (8.5)].

Hypersensitivity Reactions and Anaphylaxis
Inform patients that hypersensitivity reactions, including anaphylaxis, have occurred with administration of ANTHIM. Inform patients of the signs and symptoms of hypersensitivity reactions and anaphylaxis and instruct patients to seek immediate medical care if they experience such symptoms during or following administration of ANTHIM[see Warnings and Precautions (5.1)].

Manufactured By: 

Elusys Therapeutics, Inc.
25 Riverside Drive
Unit 1
Pine Brook, NJ 07058
U.S. License Number 1907

Your use of this website constitutes your agreement to the terms and conditions linked below:
Terms and Conditions | Resources | Sitemap
2017 © Copyright Questions?
Please contact: